Furthermore, He et al. [71] showed that non‒small cell lung cancer with repressed SPRED3 gene expression increased Ras/Raf/MAPK signaling, resulting in resistance to epidermal growth factor receptor–tyrosine kinase inhibitors. The gene discussed is EGFR; the disease is lung cancer.